Pharmacogenetics

News-Medical.Net Pharmacogenetics News Feed

Latest Pharmacogenetics News and Research
  1. FDA permits marketing of 23andme Personal Genome Service Pharmacogenetic Reports test
    Today, the U.S. Food and Drug Administration permitted marketing, with special controls, of the 23andme Personal Genome Service Pharmacogenetic Reports test as a direct-to-consumer test for providing information about genetic variants that may be associated with a patient's ability to metabolize some medications to help inform discussions with a health care provider.
  2. Beyond BRCA: Epigenetic Silencing in Breast Cancer
    An interview with Professor William Newman, discussing his recent discovery in the field of breast cancer research, and the options that this will provide for women who have a family history of breast cancer but test negative for BRCA1/2 mutations.
  3. Study highlights need for population-specific precision medicine programs in Latin America
    Drug safety and effectiveness vary greatly among populations worldwide. Genetics is one of the factors that contribute to variability in drug response.
  4. Easy and inexpensive test could one day help guide epilepsy treatment
    An easy and inexpensive test for the HLA-B*15:02 allele could one day allow clinicians to quickly identify which epilepsy patients are at risk of carbamazepine hypersensitivity, according to study results presented by Gita V. Soraya at ILAE's 2018 Asian & Oceanian Epilepsy Congress in Bali.
  5. Genetic variant discovery could improve safety, effectiveness of drugs for asthma and COPD
    Research from the University of Liverpool, published today in Lancet Respiratory Medicine, identifies a genetic variant that could improve the safety and effectiveness of corticosteroids, drugs that are used to treat a range of common and rare conditions including asthma, and chronic obstructive pulmonary disease (COPD).